Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IVVD
Stock Latest News
Ratings
Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target
7h ago
IVVD
Premium
The Fly
Midday Fly By: Ares to acquire Whitestone REIT, Disney to make ‘sizable’ layoffs
1d ago
BB
ZS
Premium
The Fly
Invivyd provides update on Phase 3 DECLARATION study of VYD2311
1d ago
IVVD
Premium
The Fly
Invivyd announces discovery, advancement of measles antibody candidate VMS063
1d ago
IVVD
Premium
Company Announcements
Invivyd Advances COVID-19 Program and Launches Measles Antibody
1d ago
8K
IVVD
Premium
Company Announcements
Invivyd Earnings Call Highlights Pivotal Trial Momentum
1M ago
IVVD
Premium
Ratings
Invivyd: Accelerating PEMGARDA Uptake and Strong Cash Runway Position VYD2311 as a De‑Risked Growth Catalyst
1M ago
IVVD
Premium
Ratings
Invivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating
1M ago
IVVD
Premium
Company Announcements
Invivyd Advances VYD2311 With Key Phase 3 Alignments
1M ago
8K
IVVD
Premium
The Fly
Invivyd reports cash, cash equivalents of $226.7M as of December 31
1M ago
IVVD
Premium
The Fly
Invivyd appoints Michael Mina as CMO
1M ago
IVVD
Premium
The Fly
Invivyd reports FY25 EPS (30c) vs. ($1.43) last year
1M ago
IVVD
Premium
Market News
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
1M ago
XBI
ERAS
Premium
The Fly
Invivyd announces peer-reviewed publication using CANOPY trial data
2M ago
IVVD
Premium
The Fly
Invivyd management to meet virtually with BTIG
2M ago
IVVD
Premium
Market News
XBI vs. IBB: Which Biotech ETF do Analysts Prefer in 2026?
2M ago
IBB
UPB
Premium
The Fly
Invivyd aligns with FDA on LIBERTY Phase 3 trial of VYD2311
2M ago
IVVD
Premium
Company Announcements
Invivyd Advances Phase 3 VYD2311 COVID-19 Prevention Trial, Keeping Optionality Alive for Investors
2M ago
IVVD
Premium
The Fly
Invivyd announces partnership with ski champion Lindsey Vonn
3M ago
IVVD
Premium
The Fly
Invivyd, SPEAR Study Group plan to initiate Phase 2 trial of VYD2311
3M ago
IVVD
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,1/9/2026, According to Top Analysts
3M ago
CMPS
IVVD
Premium
Ratings
Invivyd: Strong PEMGARDA Traction and De‑Risked COVID Antibody Pipeline Support Buy Rating and Upside Potential
3M ago
IVVD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
